Delivering care to long-term adult survivors of hematopoietic cell transplantation

Journal of Clinical Oncology

Volumn 30, Issue 30, 2012, Pages 3746-3751

  Syrjala, Karen L ^a   Martin, Paul J ^a   Lee, Stephanie J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGER; CANCER EPIDEMIOLOGY; CANCER SCREENING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DEPRESSION; EMOTIONAL STRESS; ENDOCRINE DISEASE; FATIGUE; GRAFT VERSUS HOST REACTION; HEALTH CARE DELIVERY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INSOMNIA; KIDNEY DISEASE; LUNG DISEASE; MUSCULOSKELETAL DISEASE; OSTEOLYSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHOSOCIAL DISORDER; REVIEW; SECOND CANCER; SEXUAL DYSFUNCTION; VACCINATION;

GRAFT VS HOST DISEASE; HEALTH BEHAVIOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIFE STYLE; NEOPLASMS; SURVIVORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84869213493     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.42.3038     Document Type: Review

References (56)

1. Gooley TA, Chien JW, Pergam SA, et al: Reduced mortality after allogeneic hematopoieticcell transplantation. N Engl J Med 363:2091-2101, 2010
2. Gyurkocza B, Rezvani A, Storb R: Allogeneic hematopoietic cell transplantation: The state of the art. Expert Rev Hematol 3:285-299, 2010
3. Pasquini MC, Wang Z, Horowitz MM, et al: Report from the Center for International Blood and Marrow Transplant Research (CIBMTR): Current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. Clin Transpl 2010:87-105, 2010
4. Bhatia S, Francisco L, Carter A, et al: Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: Report from the Bone Marrow Transplant Survivor Study. Blood 110:3784-3792, 2007 (Pubitemid 350159650)
5. Martin PJ, Counts GW, Appelbaum FR, et al: Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation. J Clin Oncol 28:1011-1016, 2010
6. Wingard JR, Majhail NS, Brazauskas R, et al: Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol 29: 2230-2239, 2011
7. Sun CL, Francisco L, Kawashima T, et al: Prevalence and predictors of chronic health conditions after hematopoietic cell transplantation: A report from the Bone Marrow Transplant Survivor Study. Blood 116:3129-3139, 2010
8. Fraser CJ, Bhatia S, Ness K, et al: Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: A report from the Bone Marrow Transplant Survivor Study. Blood 108:2867-2873, 2006
9. Syrjala KL, Langer SL, Abrams JR, et al: Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 291:2335-2343, 2004 (Pubitemid 38656300)
10. Ardis CM: Exercise, cachexia, and cancer therapy: A molecular rationale. Nutr Cancer 42:143-157, 2002
11. Khera N, Storer B, Flowers ME, et al: Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. J Clin Oncol 30:71-77, 2012
12. Socie G, Salooja N, Cohen A, et al: Nonmalignant late effects after allogeneic stem cell transplantation. Blood 101:3373-3385, 2003 (Pubitemid 36857917)
13. Majhail NS, Rizzo JD, Lee SJ, et al: Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant 18:348-371, 2012
14. Savani BN, Griffith ML, Jagasia S, et al: How I treat late effects in adults after allogeneic stem cell transplantation. Blood 117:3002-3009, 2011
15. Lee SJ, Vogelsang G, Flowers MED: Chronic graft-versus-host disease. Biol Blood Marrow Transplant 9:215-233, 2003 (Pubitemid 40045609)
16. Couriel D, Carpenter PA, Cutler C, et al: Ancillary therapy and supportive care of chronic graftversus-host disease: National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease - V. ancillary therapy and supportive care working group report. Biol Blood Marrow Transplant 12:375-396, 2006 (Pubitemid 43380955)
17. Sanders JE, Hoffmeister PA, Woolfrey AE, et al: Thyroid function following hematopoeitic cell transplantation in children: 30 years experience. Blood 113:306-308, 2009
18. Armenian SH, Sun CL, Mills G, et al: Predictors of late cardiovascular complications in survivors of hematopoietic cell transplantation. Biol Blood Marrow Transplant 16:1138-1144, 2010
19. Baker KS, Ness KK, Steinberger J, et al: Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: A report from the bone marrow transplantation survivor study. Blood 109:1765-1772, 2007 (Pubitemid 46239613)
20. Chow EJ, Mueller BA, Baker KS, et al: Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation. Ann Intern Med 155:21-32, 2011
21. Tichelli A, Bucher C, Rovo A, et al: Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 110:3463-3471, 2007 (Pubitemid 350106343)
22. Griffith ML, Savani BN, Boord JB: Dyslipidemia after allogeneic hematopoietic stem cell transplantation: Evaluation and management. Blood 116: 1197-1204, 2010
23. Majhail NS, Brazauskas R, Rizzo JD, et al: Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood 117:316-322, 2011
24. Rizzo JD, Curtis RE, Socié G, et al: Solid cancers after allogeneic hematopoietic cell transplantation. Blood 113:1175-1183, 2009
25. Ljungman P, Cordonnier C, Einsele H, et al: Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 44:521-526, 2009
26. Tomblyn M, Chiller T, Einsele H, et al: Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: A global perspective. Bone Marrow Transplant 44:453-455, 2009
27. Mosher CE, Redd WH, Rini CM, et al: Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: A review of the literature. Psychooncology 18:113-127, 2009
28. Syrjala KL, Kurland BF, Abrams JR, et al: Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. Blood 111:989-996, 2008 (Pubitemid 351213375)
29. Yi JC, Syrjala KL: Sexuality after hematopoietic stem cell transplantation. Cancer J 15:57-64, 2009
30. Thygesen KH, Schjødt I, Jarden M: The impact of hematopoietic stem cell transplantation on sexuality: A systematic review of the literature. Bone Marrow Transplant 47:716-724, 2012
31. Syrjala KL, Artherholt SB, Kurland B, et al: Prospective neurocognitive function over 5 years after allogeneic HCT for cancer survivors compared with matched controls at 5 years. J Clin Oncol 29:2397-2404, 2011
32. Ferguson RJ, Ahles TA, Saykin AJ, et al: Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology 16:772-777, 2007 (Pubitemid 47249179)
33. Syrjala KL, Yi JC, Artherholt SB, et al: Measuring musculoskeletal symptoms in long-term cancer survivors who receive hematopoietic cell transplantation. J Cancer Surviv 4:225-235, 2010
34. Baker KS, Loberiza FR Jr, Yu H, et al: Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. J Clin Oncol 23:7032-7042, 2005
35. Syrjala KL, Langer SL, Abrams JR, et al: Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol 23:6596-6606, 2005 (Pubitemid 46190253)
36. Wiskemann J, Huber G: Physical exercise as adjuvant therapy for patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 41:321-329, 2008 (Pubitemid 351330726)
37. Wilson RW, Jacobsen PB, Fields KK: Pilot study of a home-based aerobic exercise program for sedentary cancer survivors treated with hematopoietic stem cell transplantation. Bone Marrow Transplant 35:721-727, 2005 (Pubitemid 40520958)
38. Rajotte EJ, Yi JC, Baker KS, et al: Community-based exercise program effectiveness and safety for cancer survivors. J Cancer Surviv 6:219-228, 2012
39. Bishop MM: Psychosocial sequelae of hematopoietic cell transplantation in survivors and caregivers. Biol Blood Marrow Transplant 15:29-32, 2009
40. Rusiewicz A, DuHamel KN, Burkhalter J, et al: Psychological distress in long-term survivors of hematopoietic stem cell transplantation. Psychooncology 17:329-337, 2008 (Pubitemid 351513681)
41. Sun CL, Francisco L, Baker KS, et al: Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: A report from the Bone Marrow Transplant Survivor Study (BMTSS). Blood 118:4723-4731, 2011
42. Loberiza FR Jr, Rizzo JD, Bredeson CN, et al: Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 20:2118-2126, 2002 (Pubitemid 34408803)
43. Mosher CE, DuHamel KN, Rini C, et al: Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Support Care Cancer 19:1357-1365, 2011
44. Prieto JM, Atala J, Blanch J, et al: Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol 23:6063-6071, 2005
45. Andrykowski MA, Bishop MM, Hahn EA, et al: Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol 23:599-608, 2005 (Pubitemid 46224238)
46. Wong FL, Francisco L, Togawa K, et al: Longterm recovery after hematopoietic cell transplantation: Predictors of quality-of-life concerns. Blood 115:2508-2519, 2010
47. Wingard JR, Huang IC, Sobocinski KA, et al: Factors associated with self-reported physical and mental health after hematopoietic cell transplantation. Biol Blood Marrow Transplant 16:1682-1692, 2010
48. Mosher CE, DuHamel KN, Rini CM, et al: Barriers to mental health service use among hematopoietic SCT survivors. Bone Marrow Transplant 45:570-579, 2010
49. DuHamel KN, Mosher CE, Winkel G, et al: Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation. J Clin Oncol 28:3754-3761, 2010
50. Knols RH, de Bruin ED, Uebelhart D, et al: Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: A randomized clinical trial. Bone Marrow Transplant 46:1245-1255, 2011
51. Bishop MM, Lee SJ, Beaumont JL, et al: The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls. Biol Blood Marrow Transplant 16:207-214, 2010
52. Majhail NS, Flowers ME, Ness KK, et al: High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 43:49-54, 2009
53. Armenian SH, Sun CL, Francisco L, et al: Health behaviors and cancer screening practices in long-term survivors of hematopoietic cell transplantation (HCT): A report from the BMT Survivor Study. Bone Marrow Transplant 47:283-290, 2012
54. Lee SJ, Seaborn T, Mao FJ, et al: Frequency of abnormal findings detected by comprehensive clinical evaluation at 1 year after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 15:416-420, 2009
55. Mayer DK, Ratichek S, Berhe H, et al: Development of a health-related website for parents of children receiving hematopoietic stem cell transplant: HSCT-CHESS. J Cancer Surviv 4:67-73, 2010
56. Syrjala KL, Stover AC, Yi JC, et al: Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantation. J Cancer Surviv 5:292-304, 2011